NEW YORK (BLOOMBERG) - Another early investor of Moderna Inc is on the cusp of owning a stake worth at least US$1 billion after the biotech firm reported encouraging early trial results for an experimental Covid-19 vaccine.. Read more at straitstimes.com.
NEW YORK - Another early investor of Moderna Inc is on the cusp of owning a stake worth at least US$1 billion after the biotech firm reported encouraging early trial results for an experimental Covid-19 vaccine.
The company priced a stock offering to fund manufacturing of its coronavirus vaccine at US$76 a share, 5 per cent below the last close, people familiar with the deal said after Monday's market trading. "The broader market reaction is a measure of the need people have to perceive that there's a scientific, technological solution to this kind of battle," Afeyan said in a phone interview."We've increased expectations, but that hasn't changed what we do."
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coronavirus vaccine trial by Moderna shows promising early results
Read more »
Coronavirus vaccine from Moderna shows early signs of viral immune responseNEW YORK (BLOOMBERG) - An experimental vaccine from Moderna showed promising early signs that it can create an immune-system response in the body that could help fend off the new coronavirus, according to sampling of data from a small, first human trial of the inoculation.. Read more at straitstimes.com.
Read more »
Coronavirus vaccine from Moderna appears safe, shows promise in data from eight peopleModerna Inc's experimental COVID-19 vaccine, the first to be tested in the United States, produced protective antibodies in a small group of ...
Read more »
US: Wall St jumps at the open on coronavirus vaccine hopes[NEW YORK] US stock indexes shot up in early trade on Monday as encouraging data from a potential Covid-19 vaccine trial fueled optimism, while investors also counted on more stimulus to rescue the economy from a virus-driven slump. Read more at The Business Times.
Read more »
US firm announces 'positive interim' phase 1 results for COVID-19 vaccineWASHINGTON: US biotech firm Moderna reported 'positive interim' results on Monday (May 18) in the first clinical tests of its vaccine against the ...
Read more »